1,083
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Comparison of predicted and clinical response to radiotherapy: A radiobiology modelling study

, , , , &
Pages 584-590 | Received 18 Jun 2008, Published online: 08 Jul 2009

References

  • Dale RG. Time-dependent tumour repopulation factors in linear-quadratic equations–implications for treatment strategies. Radiother Oncol 1989; 15: 371–81
  • Brock WA, Baker FL, Peters LJ. Radiosensitivity of human head and neck squamous cell carcinomas in primary culture and its potential as a predictive assay of tumor radiocurability. Int J Radiat Biol 1989; 56: 751–60
  • Eschwege F, Bourhis J, Girinski T, Lartigau E, Guichard M, Deble D, et al. Predictive assays of radiation response in patients with head and neck squamous cell carcinoma: A review of the Institute Gustave Roussy experience. Int J Radiat Oncol Biol Phys 1997; 39: 849–53
  • Fenwick JD. Predicting the radiation control probability of heterogeneous tumour ensembles: Data analysis and parameter estimation using a closed-form expression. Phys Med Biol 1998; 43: 2159–78
  • Buffa FM, Davidson SE, Hunter RD, Nahum AE, West CM. Incorporating biologic measurements (SF(2), CFE) into a tumor control probability model increases their prognostic significance: A study in cervical carcinoma treated with radiation therapy. Int J Radiat Oncol Biol Phys 2001; 50: 1113–22
  • Deacon, J, Peckham, MJ, Steel, GG. The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiother Oncol 1984;2:317–23 ( Review).
  • Malaise EP, Fertil B, Deschavanne PJ, Chavaudra N, Brock WA. Initial slope of radiation survival curves is characteristic of the origin of primary and established cultures of human tumor cells and fibroblasts. Radiat Res 1987; 111: 319–33
  • Girinsky T, Lubin R, Pignon JP, Chavaudra N, Gazeau J, Dubray B, et al. Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas: Preliminary correlations with local control and overall survival. Int J Radiat Oncol Biol Phys 1993; 25: 3–7
  • West CM, Davidson SE, Roberts SA, Hunter RD. The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix. Br J Cancer 1997; 76: 1184–90
  • Björk-Eriksson T, West C, Karlsson E, Mercke C. Tumor radiosensitivity (SF2) is a prognostic factor for local control in head and neck cancers. Int J Radiat Oncol Biol Phys 2000; 46: 13–9
  • Bentzen, SM, Thames, HD. Clinical evidence for tumor clonogen regeneration: Interpretations of the data. Radiother Oncol 1991;22:161–6 ( Review).
  • Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988; 27: 131–46
  • Durand RE, Aquino-Parsons C. Predicting response to treatment in human cancers of the uterine cervix: Sequential biopsies during external beam radiotherapy. Int J Radiat Oncol Biol Phys 2004; 58: 555–60
  • Nordsmark M, Bentzen SM, Rudat V, Brizel D, Lartigau E, Stadler P, et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 2005; 77: 18–24
  • Janot F, Klijanienko J, Russo A, Mamet JP, de Braud F, El-Naggar AK, et al. Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: A prospective analysis. Br J Cancer 1996; 73: 531–8
  • Hall SF, Groome PA, Rothwell D, Dixon PF. Using TNM staging to predict survival in patients with squamous cell carcinoma of head & neck. Head Neck 1999; 21: 30–8
  • Yang Y, Xing L. Towards biologically conformal radiation therapy (BCRT): Selective IMRT dose escalation under the guidance of spatial biology distribution. Med Phys 2005; 32: 1473–84
  • Brodin O. The doubling time of human tumours during radiotherapy: An analysis based on comparison between clinical and in vitro tumour cell radioresponsiveness. Radiat Oncol Invest 1994; 2: 99–108
  • Steel, GG. Cell population kineticsin relation to the growth and treatment of cancer. In: Growth kinetics of tumours. Oxford; Clarendon Press; 1977.
  • Begg AC, Haustermans K, Hart AA, Dische S, Saunders M, Zackrisson B, et al. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: A multicenter analysis. Radiother Oncol 1999; 50: 13–23
  • Bentzen SM, Thames HD. Clinical evidence for tumor clonogen regeneration: Interpretations of the data. Radiother Oncol 1991; 22: 161–6
  • Britten RA, Evans AJ, Allalunis-Turner MJ, Franko AJ, Pearcey RG. Intratumoral heterogeneity as a confounding factor in clonogenic assays for tumour radioresponsiveness. Radiother Oncol 1996; 39: 145–53
  • Denekamp J. Cell kinetics and radiation biology. Int J Radiat Biol 1986; 49: 357–80
  • Tofilon PJ, Vines CM, Meyn RE, Wike J, Brock WA. Heterogeneity in radiation sensitivity within human primary tumour cell cultures as detected by the SCE assay. Br J Cancer 1989; 59: 54–60
  • Davidson SE, West CM, Roberts SA, Hendry JH, Hunter RD. Radiosensitivity testing of primary cervical carcinoma: Evaluation of intra- and inter-tumour heterogeneity. Radiother Oncol 1990; 18: 349–56
  • Wilson MS, West CM, Wilson GD, Roberts SA, James RD, Schofield PF. Intra-tumoral heterogeneity of tumour potential doubling times (Tpot) in colorectal cancer. Br J Cancer 1993; 68: 501–6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.